Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders (PACT)
This study is currently recruiting participants.
(see Contacts and Locations)
Verified February 2015 by Columbia University
Sponsor:
Columbia University
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Nabila El-Bassel, PhD, Columbia University
ClinicalTrials.gov Identifier:
NCT01690494
First received: September 19, 2012
Last updated: February 2, 2015
Last verified: February 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated HIV and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with misdemeanors and their primary female sexual partners, implemented by frontline providers in Criminal Court, Community Court or probation (CCP) sites in NYC, compared to CCP standard treatment of care services (TAU). The primary outcomes are to reduce sexually transmitted infections (STIs) and increase condom use.
| Condition | Intervention |
|---|---|
|
Sexually Transmitted Diseases Unsafe Sex Substance-Related Disorders |
Behavioral: PACT Behavioral: TAU |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders, An Effectiveness Trial |
Resource links provided by NLM:
Further study details as provided by Columbia University:
Primary Outcome Measures:
- Change in biologically confirmed sexually transmitted infections [ Time Frame: Baseline and up to 12 months post intervention ] [ Designated as safety issue: No ]
- Change in proportion of unprotected sexual acts [ Time Frame: Baseline and up to 12 months post intervention ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Change in drug use [ Time Frame: Baseline and up to 12 months post intervention ] [ Designated as safety issue: No ]
- Change in utilization of drug treatment [ Time Frame: Baseline and up to 12 months post intervention ] [ Designated as safety issue: No ]
- Change in recidivism [ Time Frame: Up to 12 months post intervention ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 480 |
| Study Start Date: | June 2013 |
| Estimated Primary Completion Date: | July 2017 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: PACT + TAU
4-session PACT delivered to both partners together + standard treatment of care services (TAU) delivered to the male participant
|
Behavioral: PACT
Couple-based behavioral HIV/STI preventive intervention
Behavioral: TAU
Standard treatment of care services provided to male offenders by the Criminal Court, Community Court or probation sites
|
|
Active Comparator: TAU
TAU control condition delivered to the male participant
|
Behavioral: TAU
Standard treatment of care services provided to male offenders by the Criminal Court, Community Court or probation sites
|
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Couples
- Both partners are aged 18 or older
- Identify each other as their primary sexual partner of opposite sex
- Relationship has existed at least 3 months
- At least one partner reports having unprotected vaginal or anal intercourse with the other partner in the past 90 days
- At least one partner reports exposure to an outside HIV risk in the past year
- Male partner reports and is verified by court records of being charged with a misdemeanor
- Male partner is currently under court supervision or probation
Exclusion Criteria:
- Either partner shows evidence of significant psychiatric or could impairment as confirmed by the MacArthur Competence Assessment Tool during the screening eligibility interview.
- Either partner reports severe physical or sexual violence perpetrated by the other partner in the past year as measured on the Revised Conflict Tactics Scale
- Either partner is unable to commit to participate in the study through to completion
- Either partner reports that the couple is planning a pregnancy within the next 12 months
- Either partner is not fluent in English as determined during Informed Consent
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01690494
Please refer to this study by its ClinicalTrials.gov identifier: NCT01690494
Contacts
| Contact: Nabila El-Bassel, DSW | 212-851-2431 | ne5@columbia.edu |
Locations
| United States, New York | |
| Columbia University | Recruiting |
| New York, New York, United States, 10027 | |
| Contact: Dawn Goddard, MS 212-851-2120 | |
Sponsors and Collaborators
Columbia University
National Institute on Drug Abuse (NIDA)
Investigators
| Principal Investigator: | Nabila El-Bassel, DSW | Columbia University |
More Information
Publications:
| Responsible Party: | Nabila El-Bassel, PhD, Professor of Social Work, Columbia University |
| ClinicalTrials.gov Identifier: | NCT01690494 History of Changes |
| Other Study ID Numbers: | AAAK0206 1R01DA033168-01A1 |
| Study First Received: | September 19, 2012 |
| Last Updated: | February 2, 2015 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Columbia University:
|
STI sexually transmitted infection HIV criminal justice |
probation couples drug use |
Additional relevant MeSH terms:
|
Substance-Related Disorders Sexually Transmitted Diseases Chemically-Induced Disorders Mental Disorders |
Infection Virus Diseases Genital Diseases, Male Genital Diseases, Female |
ClinicalTrials.gov processed this record on September 27, 2016